2m 2m 2m 2m 2m 2m 2m
VIRIDIAN THERAPT (VRDN)
NASDAQ
$17.59-$0.04 (-0.26%)
Price as of Jun 23, 2026 5:11 PM EDT- $1.9BMarket Cap
- 19.85%1-Year Change
- BiotechnologyIndustry
VIRIDIAN THERAPT (VRDN)
$17.59-$0.04 (-0.26%)
VRDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.63 | ||
Change | +$1.00 (+6.01%) | ||
Open | $16.93 | ||
High | $18.18 | ||
Low | $16.93 | ||
Previous Close | $16.63 | ||
Volume | 2,549,626 | ||
30-Day Average Volume | 1,653,236 | ||
1-Week Change | 8.16% | ||
1-Month Change | 2.26% | ||
1-Year Change | 19.85% | ||
3-Year Change | -33.87% | ||
5-Year Change | 1.79% | ||
Fundamentals | |||
Shares Outstanding | 110.4M | ||
Total Assets | $789.0M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $6,000.00 | ||
Net Income | -$104.9M | ||
Free Cash Flow | -$119.7M | ||
EBIT | -$104.9M | ||
EBITDA | -$104.8M | ||
Net Working Capital | $732.9M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 309,504 | ||
P/B | 3 | ||
P/E | -20 | ||
PEG | -1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 11/13/2020 | ||
Earnings & Revenue